PMVP Latest Press Releases

-- November 4, 2026 --

Pivotal Phase 2 Rezatapopt PYNNACLE Data to Be Featured in Late-Breaking Oral Presentation at ENA 2026 Globe Newswire 8:00 AM

-- October 5, 2026 --

PMV Pharmaceuticals Appoints Matt Eckler, Ph.D., to Board of Directors Globe Newswire 8:00 AM

-- September 8, 2026 --

PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer Globe Newswire 8:00 AM

-- August 31, 2026 --

PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities Globe Newswire 11:03 PM

PMV Pharma Announces Proposed Public Offering of Securities Globe Newswire 4:02 PM

PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial Globe Newswire 4:01 PM

-- August 14, 2026 --

PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes